OVAMIR Trademark

Trademark Overview

On Friday, September 16, 2022, a trademark application was filed for OVAMIR with the United States Patent and Trademark Office. The USPTO has given the OVAMIR trademark a serial number of 97594340. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Tuesday, December 10, 2024. This trademark is owned by AptamiR Therapeutics, Inc.. The OVAMIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
ovamir

General Information

Serial Number97594340
Word MarkOVAMIR
Filing DateFriday, September 16, 2022
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateTuesday, December 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 3, 2022
Primary Code005
First Use Anywhere DateFriday, September 16, 2022
First Use In Commerce DateFriday, September 16, 2022

Trademark Owner History

Party NameAptamiR Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNAPLES, FL 341191814
Party NameAptamiR Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNAPLES, FL 341191814

Trademark Events

Event DateEvent Description
Tuesday, September 20, 2022NEW APPLICATION ENTERED
Monday, October 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 17, 2023ASSIGNED TO EXAMINER
Wednesday, May 17, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2024SOU EXTENSION 1 GRANTED
Tuesday, February 13, 2024SOU EXTENSION 1 FILED
Wednesday, February 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 15, 2024SOU EXTENSION 2 FILED
Monday, September 16, 2024USE AMENDMENT FILED
Monday, September 16, 2024NOTICE OF REVIVAL - E-MAILED
Monday, September 16, 2024PETITION TO REVIVE-GRANTED
Monday, September 16, 2024TEAS PETITION TO REVIVE RECEIVED
Monday, September 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 16, 2024TEAS STATEMENT OF USE RECEIVED
Monday, September 16, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, November 15, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 19, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 19, 2024SOU EXTENSION 2 GRANTED
Tuesday, November 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 10, 2024NON-FINAL ACTION E-MAILED
Tuesday, December 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 10, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, December 10, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, December 10, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Related Keywords

ovamir gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related